Gland Pharma Limited (GLAND.NS)

INR 1426.3

(2.34%)

Operating Expenses Summary of Gland Pharma Limited

  • Gland Pharma Limited's latest annual operating expenses in 2023 was 14.65 Billion INR , down -36.7% from previous year.
  • Gland Pharma Limited's latest quarterly operating expenses in 2024 Q2 was 1.58 Billion INR , down -7.53% from previous quarter.
  • Gland Pharma Limited reported a annual operating expenses of 10.61 Billion INR in annual operating expenses 2022, up 21.34% from previous year.
  • Gland Pharma Limited reported a annual operating expenses of 8.74 Billion INR in annual operating expenses 2021, up 20.12% from previous year.
  • Gland Pharma Limited reported a quarterly operating expenses of 1.58 Billion INR for 2024 Q2, down -7.53% from previous quarter.
  • Gland Pharma Limited reported a quarterly operating expenses of 6.71 Billion INR for 2023 FY, down -36.7% from previous quarter.

Annual Operating Expenses Chart of Gland Pharma Limited (2023 - 2016)

Historical Annual Operating Expenses of Gland Pharma Limited (2023 - 2016)

Year Operating Expenses Operating Expenses Growth
2023 14.65 Billion INR -36.7%
2022 10.61 Billion INR 21.34%
2021 8.74 Billion INR 20.12%
2020 7.28 Billion INR 19.89%
2019 6.07 Billion INR 16.27%
2018 5.22 Billion INR 13.26%
2017 4.61 Billion INR 39.09%
2016 3.31 Billion INR 0.0%

Peer Operating Expenses Comparison of Gland Pharma Limited

Name Operating Expenses Operating Expenses Difference
Abbott India Limited 5.98 Billion INR -144.836%
Cipla Limited 59.21 Billion INR 75.25%
GlaxoSmithKline Pharmaceuticals Limited 4.35 Billion INR -236.359%
Kopran Limited 1.41 Billion INR -935.203%
Marksans Pharma Limited 3.28 Billion INR -345.559%
NGL Fine-Chem Limited 1.75 Billion INR -737.388%
Pfizer Limited 4.33 Billion INR -237.923%
Sanofi India Limited 4.13 Billion INR -254.704%
SMS Pharmaceuticals Limited 769.2 Million INR -1805.391%
TTK Healthcare Limited 3.72 Billion INR -293.845%